GoodRx Holdings Inc. (NASDAQ: GDRX) kicked off on May 22, 2023, at the price of $5.08, up 3.54% from the previous trading day. During the day, the shares moved up to $5.305 and dropped to $5.04 before settling in for the closing price of $5.08. Over the past 52 weeks, GDRX has traded in a range of $3.82-$10.37.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 37.30% over the past five years. While this was happening, its average annual earnings per share was recorded -29.10%. With a float of $75.59 million, this company’s outstanding shares have now reached $412.43 million.
Let’s look at the performance matrix of the company that is accounted for 952 employees. In terms of profitability, gross margin is +84.50, operating margin of +4.85, and the pretax margin is -3.03.
GoodRx Holdings Inc. (GDRX) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of GoodRx Holdings Inc. is 1.80%, while institutional ownership is 69.50%.
GoodRx Holdings Inc. (GDRX) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 3/30/2023, the organization reported $0.07 earnings per share (EPS), higher than consensus estimate (set at $0.06) by $0.01. This company achieved a net margin of -4.28 while generating a return on equity of -3.99. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -29.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.01% during the next five years compared to -25.10% drop over the previous five years of trading.
GoodRx Holdings Inc. (NASDAQ: GDRX) Trading Performance Indicators
Take a look at GoodRx Holdings Inc.’s (GDRX) current performance indicators. Last quarter, stock had a quick ratio of 13.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.83. Likewise, its price to free cash flow for the trailing twelve months is 23.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.12, a number that is poised to hit 0.06 in the next quarter and is forecasted to reach 0.30 in one year’s time.
Technical Analysis of GoodRx Holdings Inc. (GDRX)
GoodRx Holdings Inc. (NASDAQ: GDRX) saw its 5-day average volume 0.96 million, a negative change from its year-to-date volume of 1.57 million. As of the previous 9 days, the stock’s Stochastic %D was 86.89%. Additionally, its Average True Range was 0.28.
During the past 100 days, GoodRx Holdings Inc.’s (GDRX) raw stochastic average was set at 38.24%, which indicates a significant decrease from 95.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.92% in the past 14 days, which was lower than the 56.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.60, while its 200-day Moving Average is $5.45. Nevertheless, the first resistance level for the watch stands at $5.36 in the near term. At $5.47, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.63. If the price goes on to break the first support level at $5.10, it is likely to go to the next support level at $4.94. Assuming the price breaks the second support level, the third support level stands at $4.83.
GoodRx Holdings Inc. (NASDAQ: GDRX) Key Stats
The company with the Market Capitalisation of 2.11 billion has total of 396,868K Shares Outstanding. Its annual sales at the moment are 766,550 K in contrast with the sum of -32,830 K annual income. Company’s last quarter sales were recorded 183,990 K and last quarter income was -3,290 K.
